Further to letter dated May 13, 2025, intimating about the date of the Board of Directors Meeting to, consider and approve the standalone and consolidated audited financial results of the Company for the quarter and financial year ended March 31, 2025, Eris Lifesciences has informed that pursuant to regulation 30 and other applicable regulations, if any, of the SEBI (LODR) Regulations, 2015, the Company will hold a conference call for analysts and investors on Monday, May 19, 2025, at 04:00 pm IST. The details of the said call are attached and are also available on Company’s website.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: